Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14708-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14708-1-AP, RRID:AB_2159487
- Product name
- PAPSS1 antibody
- Antibody type
- Polyclonal
- Description
- PAPSS1 antibody (Cat. #14708-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning.
Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis.
Glycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosis.
Correlation of 3'-phosphoadenosine-5'-phosphosulfate synthase 1 (PAPSS1) expression with clinical parameters and prognosis in esophageal squamous cell carcinoma.
Modulating tyrosine sulfation of recombinant antibodies in CHO cell culture by host selection and sodium chlorate supplementation.
CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.
Chen J, Li Q, Liu X, Lin F, Jing Y, Yang J, Zhao L
Frontiers in molecular biosciences 2025;12:1529507
Frontiers in molecular biosciences 2025;12:1529507
Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis.
Calhoon D, Sang L, Ji F, Bezwada D, Hsu SC, Cai F, Kim N, Basu A, Wu R, Pimentel A, Brooks B, La K, Paulina Serrano A, Cassidy DL, Cai L, Toffessi-Tcheuyap V, Moussa ME, Uritboonthai W, Hoang LT, Kolli M, Jackson B, Margulis V, Siuzdak G, Brugarolas J, Corbin I, Pratt DA, Weiss RJ, DeBerardinis RJ, Birsoy K, Garcia-Bermudez J
Nature 2025 Aug;644(8077):799-808
Nature 2025 Aug;644(8077):799-808
Glycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosis.
Calhoon D, Sang L, Bezwada D, Kim N, Basu A, Hsu SC, Pimentel A, Brooks B, La K, Serrano AP, Cassidy DL, Cai L, Toffessi-Tcheuyap V, Margulis V, Cai F, Brugarolas J, Weiss RJ, DeBerardinis RJ, Birsoy K, Garcia-Bermudez J
bioRxiv : the preprint server for biology 2024 May 13;
bioRxiv : the preprint server for biology 2024 May 13;
Correlation of 3'-phosphoadenosine-5'-phosphosulfate synthase 1 (PAPSS1) expression with clinical parameters and prognosis in esophageal squamous cell carcinoma.
Zhu X, Zhu P, Chen X, Zhang L, Wu C, Zhang H, Shen X, Qi Y, Chen M, Wang S, Yi X
Histology and histopathology 2023 Nov;38(11):1327-1335
Histology and histopathology 2023 Nov;38(11):1327-1335
Modulating tyrosine sulfation of recombinant antibodies in CHO cell culture by host selection and sodium chlorate supplementation.
Liu R, Zhang Y, Kumar A, Huhn S, Hullinger L, Du Z
Biotechnology journal 2021 Sep;16(9):e2100142
Biotechnology journal 2021 Sep;16(9):e2100142
CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.
Zhu W, Jarman KE, Lokman NA, Neubauer HA, Davies LT, Gliddon BL, Taing H, Moretti PAB, Oehler MK, Pitman MR, Pitson SM
Cancer research 2017 Sep 15;77(18):4823-4834
Cancer research 2017 Sep 15;77(18):4823-4834
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HepG2 cells were subjected to SDS PAGE followed by western blot with 14708-1-AP(PAPSS1 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PAPSS1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PAPSS1. This antibody recognizes human, mouse, rat antigen. The PAPSS1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
